According to an official statement published on 17 June 2011, the German Federal Ministry of Education and Research (BMBF) intends to secure and further Germany’s leading position in international comparison in the field of alternative methods to animal experiments (in the sense of the 3R principles of Russel & Burch).

Under the name of “Spinnovator”, the venture capitalist Vesalius Biocapital and the technology transfer company Ascenion have developed a new financial instrument for the practical implementation of promising results from public research.

25 experts accepted the invitation of the Paul-Ehrlich Institute (PEI) in Langen, Germany, and convened on the 9th and 10th of June for a workshop on alternatives to the use of animals for testing whooping cough vaccines.

Scientists at the Fraunhofer Institute for Cell Therapies and Immunology (IZI) Leipzig, Germany, have developed an alternative to established antibiotics. In the future it will be possible to use antimicrobial peptides instead of ineffective antibiotics for combating pathogens.

Allergan Inc. (NYSE:AGN) got the approval for a fully in vitro, cell-based assay for use in the stability and potency testing of BOTOX® (onabotulinumtoxinA) and BOTOX® Cosmetic from the United States Food and Drug Administration (FDA).

Communicating Biological Barriers

Friday, 27 May 2011 17:53

With "InLiveTox", a project supported by the European Union, scientists for the first time interconnect three biological barriers in one sigle "in vitro model". With that they want to simulate nature related conditions like in human body.

InvitroJobs will present scientists and their innovative research in a regular feature called “Working Group – a Portrait”. We will focus on newly developed methods, their evaluation and their potential for reducing and where possible replacing animal experimentation according to the 3R principle of Russel & Burch (reduce, refine, replace).
The series will continue with the research group "Experimental Cell- and Tissue Technology", which is within the working group "Molecular Haemostaseology" at the University Hospital of Jena. The presentation is followed by an interview with Dr. rer. nat Sandy Mosig.

In future it will be possible to produce economically antibodies, holding a key role in the investigation of biological and medical questions, without the use of animals in large numbers.

For the first time ever in the world, researchers at the Sahlgrenska Academy at the University of Gothenburg, Sweden, have produced a blood vessel from stem cells and then used it in an operation on a 10-year-old girl at the Sahlgrenska University Hospital.

Researchers in Bochum have produced an antibody that allows them to distinguish the numerous types of stem cells in the nervous system better than before.